{"id": "1386213389148508161", "creation": 1619334001.0, "user_id": "1164940374374330368", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 18, "reply_count": 2, "like_count": 82, "quote_count": 1}}, "text": "China\u2019s #Sinopharm has commenced phase-1 and phase-2 clinical trials for its new recombinant #vaccine against #COVID19 in C China's Henan since Sat after receiving a clinical research permit on Apr 9. The early-staged trials were randomized, double-blind, and placebo-controlled. https://t.co/uxjDZIHpBD", "first_save": 1634559108.199414, "hashtags": ["#SINOPHARM", "#VACCINE", "#COVID19"]}